UofL Health's Mary & Elizabeth Hospital in Louisville, Ky., has opened its own full-service pharmacy, according to a July 27 news release. 

A phase 3 trial of an oral drug called zuranolone significantly improved symptoms of postpartum depression in just 15 days.

Indiana University Health, based in Indianapolis, recently unveiled its $40 million, 70,000-square-foot shared services pharmacy facility, according to a news release shared with Becker's. 

Kaiser Permanente Pharmacy ranked No. 1 for customer satisfaction among mail-order pharmacies in the J.D. Power 2023 U.S. Pharmacy Study. 

Thirteen essential drugs made at Pfizer's Rocky Mount, N.C., facility — which was recently damaged by a tornado — have a vulnerability score higher than 90 percent, according to a July 26 report from United States Pharmacopeia. 

The Institute for Safe Medical Practices has revised its list of look-alike drug names that are often confused, adding more than 80 drug pairs to the resource. 

Novo Nordisk is reporting shortages of Ozempic, Wegovy, Saxenda and, recently, Eli Lilly has reported shortages of Mounjaro, a Type 2 diabetes drug that might be approved for weight loss if clinical trials find success.

The World Health Organization decided to not add GLP-1 receptor agonists indicated for weight loss, such as Wegovy, to its 2023 essential medicines list, which includes about 500 drugs.

Pfizer told hospital buyers that 65 of its products "may experience continued or new supply disruptions in the near term" because less than three months' worth of supply is in the market. 

Following reports of sunken faces, muscle mass loss and malnutrition with Ozempic, another rare side effect has popped up: severe gastroparesis, or stomach paralysis.